Neutrolis Inc
PrivateLast Round
Series B
Oct 29, 2025
Total Funding Raised
$33.56M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Neutrolis Inc is a biotechnology company that develops precision therapies for autoimmune and inflammatory diseases by targeting Neutrophil Extracellular Traps (NETs).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neutrolis Inc Comparables
Compare Neutrolis Inc with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ardiyon Bio | 85% | |
| Citryll | 81% | |
| Sonoma Biotherapeutics | 64% |
Neutrolis Inc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 29, 2025 | ||||
| VC Round | Jul 8, 2025 | ||||
| VC Round | Feb 28, 2025 | ||||
| Series A | Dec 3, 2021 | ||||
| Grant | Aug 3, 2020 | ||||
Accelerator | Nov 28, 2017 |
Key People
Founding team and executive leadership
Neutrolis Inc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| NIH RADx | Grant |
| Prefix Capital | VC Round, Series A, Seed |
| PBJ Capital | VC Round, Series A |
| Pfizer | Accelerator |
| Morningside Group | Series A |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 46% MoM.
- Apr 15, 2026
Caren Deardorf appointed as Chief Business & Strategy Officer.
Recent news
Latest coverage and updates
- is_developingJul 16, 2026
Neutrolis, Inc. is developing DNASE1L3-based therapies on Jul 16th '26.
Neutrolis Inc Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Neutrolis Inc's valuation, stock price, and market status.
Is Neutrolis Inc a public or private company?
Neutrolis Inc is a private company.
What is the current stock price of Neutrolis Inc?
Neutrolis Inc is a private company with no public stock price. No recent secondary market data is available.
How much is Neutrolis Inc worth (valuation)?
Valuation information for Neutrolis Inc is not publicly available.
Can I buy Neutrolis Inc stock?
Neutrolis Inc shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Neutrolis Inc's last funding round?
Neutrolis Inc's most recent funding round was VC Round on July 8, 2025.
Who are the main investors in Neutrolis Inc?
Key investors in Neutrolis Inc include U.S. Department of Health and Human Services, NIH RADx, Prefix Capital, PBJ Capital, National Institutes of Health (NIH).
Will Neutrolis Inc IPO soon?
No public IPO plans have been announced for Neutrolis Inc.
How can I track Neutrolis Inc secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neutrolis Inc's secondary market activity and sign up for updates.